Zhang, Lanju
Wang, Zailong
Wang, Li
Cui, Lu
Sokolove, Jeremy
Chan, Ivan
Article History
Received: 26 February 2021
Revised: 8 March 2022
Accepted: 10 March 2022
First Online: 31 March 2022
Declarations
:
: This manuscript was supported by AbbVie. AbbVie participated in the review and approval of the content. Lanju Zhang is a former AbbVie employee and is currently employed by Vertex Pharmaceuticals. Zailong Wang and Li Wang are employees of AbbVie Inc. Lu Cui is a former AbbVie employee and is currently employed by UCB Biosciences Inc. Jeremy Sokolove is a former AbbVie employee and is currently employed by GlaxoSmithKline. Ivan Chan is a former AbbVie employee and currently employed by Bristol Myers Squibb. All authors may own AbbVie stock.